Celltrion Pharm

068760.KQ

39.50 USD

0.27

+0.69%

Overview

Last close

39.50 usd

Market cap

1.72B usd

52 week high

83.01 usd

52 week low

30.18 usd

Target price

98.63 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

8.5814

Price/Book Value

5.8602

Enterprise Value

1.76B usd

EV/Revenue

4.9252

EV/EBITDA

37.4558

Key financials

Revenue TTM

199.23M usd

Gross Profit TTM

58.63M usd

EBITDA TTM

31.04M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

458.65M usd

Net debt

N/A usd

About

Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea.